GTEx Nerve 20-29 vs 70-79 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Nerve 20-29 vs 70-79 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Nerve 20-29 vs 70-79 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Nerve 20-29 vs 70-79 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Nerve 20-29 vs 70-79 Down.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 1291

Gene

lung cancer associated transcript 1

Gene

long intergenic non-protein coding RNA 1806

Gene

arylacetamide deacetylase pseudogene 1

Gene

MIR924 host gene

Gene

KRT7 antisense RNA 1

Gene

lncRNA osteogenesis associated

Gene

BCL2 interacting protein 3 pseudogene 17

Gene

long intergenic non-protein coding RNA 1484

Gene

long intergenic non-protein coding RNA 1235

  • Gene

    long intergenic non-protein coding RNA 1291


  • Gene

    lung cancer associated transcript 1


  • Gene

    long intergenic non-protein coding RNA 1806


  • Gene

    arylacetamide deacetylase pseudogene 1



  • Gene

    KRT7 antisense RNA 1


  • Gene

    lncRNA osteogenesis associated


  • Gene

    BCL2 interacting protein 3 pseudogene 17


  • Gene

    long intergenic non-protein coding RNA 1484


  • Gene

    long intergenic non-protein coding RNA 1235

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.